These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 25254472)

  • 1. Network biology: A compass for stem-cell differentiation.
    Müller FJ; Loring JF
    Nature; 2014 Sep; 513(7519):498-9. PubMed ID: 25254472
    [No Abstract]   [Full Text] [Related]  

  • 2. Concise review: Human cell engineering: cellular reprogramming and genome editing.
    Mali P; Cheng L
    Stem Cells; 2012 Jan; 30(1):75-81. PubMed ID: 21905170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cell bioengineering: building from stem cell biology.
    Tewary M; Shakiba N; Zandstra PW
    Nat Rev Genet; 2018 Oct; 19(10):595-614. PubMed ID: 30089805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obstacles in Renal Regenerative Medicine: Metabolic and Epigenetic Parallels Between Cellular Reprogramming and Kidney Cancer Oncogenesis.
    Lichner Z; Mac-Way F; Yousef GM
    Eur Urol Focus; 2019 Mar; 5(2):250-261. PubMed ID: 28847686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posttranscriptional (Re)programming of Cell Fate: Examples in Stem Cells, Progenitor, and Differentiated Cells.
    Kanellopoulou C; Muljo SA
    Front Immunol; 2018; 9():715. PubMed ID: 29686685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of Polycomb Repressive Complex 2 in Maturation of Induced Pluripotent Stem Cells during Reprogramming of Mouse and Human Fibroblasts.
    Khazaie N; Massumi M; Wee P; Salimi M; Mohammadnia A; Yaqubi M
    PLoS One; 2016; 11(3):e0150518. PubMed ID: 26938987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A menagerie of stem-cell models.
    Madhusoodanan J
    Nature; 2020 Sep; 585(7826):623-624. PubMed ID: 32963372
    [No Abstract]   [Full Text] [Related]  

  • 8. Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds.
    Hou P; Li Y; Zhang X; Liu C; Guan J; Li H; Zhao T; Ye J; Yang W; Liu K; Ge J; Xu J; Zhang Q; Zhao Y; Deng H
    Science; 2013 Aug; 341(6146):651-4. PubMed ID: 23868920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cells: Troublesome memories.
    Zwaka TP
    Nature; 2010 Sep; 467(7313):280-1. PubMed ID: 20844526
    [No Abstract]   [Full Text] [Related]  

  • 10. Novel Markov model of induced pluripotency predicts gene expression changes in reprogramming.
    Hu Z; Qian M; Zhang MQ
    BMC Syst Biol; 2011; 5 Suppl 2(Suppl 2):S8. PubMed ID: 22784579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic insights into reprogramming to induced pluripotency.
    Ho R; Chronis C; Plath K
    J Cell Physiol; 2011 Apr; 226(4):868-78. PubMed ID: 20945378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deciphering the heterogeneity in DNA methylation patterns during stem cell differentiation and reprogramming.
    Shao X; Zhang C; Sun MA; Lu X; Xie H
    BMC Genomics; 2014 Nov; 15(1):978. PubMed ID: 25404570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Collective Histone State Dynamics on Epigenetic Landscape and Kinetics of Cell Reprogramming.
    Ashwin SS; Sasai M
    Sci Rep; 2015 Nov; 5():16746. PubMed ID: 26581803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic Variation between Human Induced Pluripotent Stem Cell Lines Is an Indicator of Differentiation Capacity.
    Nishizawa M; Chonabayashi K; Nomura M; Tanaka A; Nakamura M; Inagaki A; Nishikawa M; Takei I; Oishi A; Tanabe K; Ohnuki M; Yokota H; Koyanagi-Aoi M; Okita K; Watanabe A; Takaori-Kondo A; Yamanaka S; Yoshida Y
    Cell Stem Cell; 2016 Sep; 19(3):341-54. PubMed ID: 27476965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-based system in stem cell reprogramming; differentiation/dedifferentiation.
    Pourrajab F; Babaei Zarch M; BaghiYazdi M; Hekmatimoghaddam S; Zare-Khormizi MR
    Int J Biochem Cell Biol; 2014 Oct; 55():318-28. PubMed ID: 25150833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental approaches for the generation of induced pluripotent stem cells.
    Sommer CA; Mostoslavsky G
    Stem Cell Res Ther; 2010 Aug; 1(3):26. PubMed ID: 20699015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic Aberrations Are Not Specific to Transcription Factor-Mediated Reprogramming.
    Tiemann U; Wu G; Marthaler AG; Schöler HR; Tapia N
    Stem Cell Reports; 2016 Jan; 6(1):35-43. PubMed ID: 26711876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ground rules of the pluripotency gene regulatory network.
    Li M; Belmonte JC
    Nat Rev Genet; 2017 Mar; 18(3):180-191. PubMed ID: 28045100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standardization of human stem cell pluripotency using bioinformatics.
    Nestor MW; Noggle SA
    Stem Cell Res Ther; 2013 Apr; 4(2):37. PubMed ID: 23680084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing iPSC reprogramming methods for their suitability in translational medicine.
    Rao MS; Malik N
    J Cell Biochem; 2012 Oct; 113(10):3061-8. PubMed ID: 22573568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.